A five-year RCPI dual-certification SpR programme in Endocrinology and Diabetes Mellitus and General Internal Medicine with a mandatory European Board or UK SCE examination in year 3 or 4.
Duration: 5 years (SpR1-SpR5): four clinical years plus one year that may be full-time research; dual CSCST with General Internal Medicine
Annual intake: 12 HST Year 1 trainees in 2024/2025 (44 endocrinology SpRs across all years) - HSE NDTP Medical Workforce Report 2024-2025, Table 7
Applications: July 2027 intake: applications opened 1 October 2026 at noon and close 29 October 2026 at 5pm, Irish time. In-person interview date: 3 and 4 February 2027.
Entry: After BST in General Internal Medicine (or approved equivalent) + MRCPI in General Medicine. IMC registration eligibility, English language competency and eligibility to work in Ireland required at application. For MRCPI applicants, RCPI’s FAQ gives 31 December 2026 for the relevant Clinical pass, while its entry guidance says before interview. Confirm the applicable deadline with RCPI.
Exams: 2026/27 curriculum: all trainees must sit either the European Board Examination in Endocrinology, Diabetes and Metabolism (EBEEDM) or the UK Specialty Certificate Examination in Endocrinology and Diabetes in Year 3 or 4 of HST.
Endocrinologists investigate hormone disorders and care for people with diabetes. Much of the specialty takes place in clinics, alongside acute care of problems such as diabetic ketoacidosis and adrenal crisis. Thyroid, pituitary, adrenal, reproductive and metabolic disease create a broad diagnostic workload; multidisciplinary clinics and long-term patient relationships are common.
HST Endocrinology and Diabetes Mellitus is a five-year RCPI programme leading to dual CSCST with General Internal Medicine. The 2026/27 curriculum describes four clinical years and a year that may be credited from full-time research or other approved academic experience. Trainees must sit either the European Board examination or UK Specialty Certificate Examination in Endocrinology and Diabetes in Year 3 or 4.
Entry requires BST in General Internal Medicine (or equivalent) and MRCPI in General Medicine, with the applicable Clinical pass deadline subject to the conflicting RCPI guidance noted below. For the 2027 intake, shortlisting is scored out of 20, including 6 marks for clinical practice and suitability. The interview is scored out of 100 across four equally weighted domains. Twelve trainees entered year 1 in 2024/2025.
Qualification deadline for 2027 entry
RCPI’s 2027 application FAQ gives 31 December 2026 for the relevant MRCPI Clinical examination, while its entry guidance says before interview. Confirm the applicable deadline with RCPI for your specialty and entry route.
How selection is scored
Shortlistingmax 20
Professional qualifications / education5
Publication and audit experience5
Clinical practice and suitability6
Leadership and management2
Teaching experience2
Current RCPI 2027 HST entry guidance, checked 24 October 2026.
Current RCPI 2027 HST entry guidance, checked 24 October 2026.
Where you train
Named hospital lists are not published per specialty; SpRs rotate through RCPI-approved training sites nationally in preapproved 6- or 12-month posts. At least one clinical year must be completed in a training site outside the Dublin area; a maximum of two clinical years may be spent in the same site.
Where this leads
Award of CSCST (dual certification in Endocrinology & Diabetes Mellitus and General Internal Medicine) confers eligibility for entry on the Specialist Division of the IMC register and for consultant posts. Documented post-CSCST routes: the RCPI/HSE register of approved Post-CSCST Fellowship posts and HSE NDTP Aspire Fellowships, open to doctors within two years of CSCST.
Entry and selection guidance checked 26 October 2026.
Facts last verified 2026-07-27. Content updated 2026-10-26.
We use cookies to save your ranking progress and preferences. Strictly necessary cookies keep the tool working. Optional cookies help us understand how the tool is used.